Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact ...
Le doliprane vendu aux américains ? C'est le scandale industriel qui a occupé les politiques la semaine dernière. Le géant ...
Learn how the body's own protein-making machinery can be used to create new vaccines and medicines.
EVolutive Facilities are state-of-the-art industrial sites. Fully digitalized, they will enable more responsive and flexible ...
Why has our logo changed? Because we have changed. We've connected the dots to unite as one company behind a bold, new ...
Paul Hudson, CEO of Sanofi, joins 'Power Lunch' to discuss solutions-oriented approaches for the pharmaceutical industry, and ...
At Sanofi, we chase the miracles of science, and we know Digital & Data have a role to play in the future of health. We're ...
[ERRATUM] Une erreur de pourcentage s'est glissée à 33:19. Le chiffre de 63 % de l'actionnariat étranger est correct, mais celui ...
Aug.17 -- Sanofi has agreed to acquire Principia Biopharma Inc. in a $3.4 billion deal. The move comes as the French drug maker ...